Monthly Archives: September 2023

Severity Reduced With Mpox Reinfection, Postvaccination Infection

MONDAY, Sept. 11, 2023 (HealthDay News) — The clinical features and outcomes of mpox reinfection and infection postvaccination are less clinically severe than initial infection, according to a global case series published online Sept. 4 in The Lancet Infectious Diseases. Aniruddha Hazra, M.D., from the University of Chicago Medicine, and colleagues describe the epidemiological and […]

DOH logs 894 COVID-19 infections from Sept. 4 to 10

MANILA, Philippines — The Department of Health (DOH) on Monday said it recorded 894 COVID-19 infections from September 4 to 10, slightly higher than the 780 infections recorded the previous week. ADVERTISEMENT Based on the DOH’s latest data, the latest weekly total translated to a daily average of 128 cases, 15 percent higher than the […]

By offering a detailed analysis of market challenges, sales volume, share, and forecast research, this report projects the 4.1% CAGR growth rate of the Bleeding Disorders Treatment market’s growing market size year on year.

The “Bleeding Disorders Treatment Market” is segmented into regions, Applications, and Types. The report presents the research and analysis provided within the Bleeding Disorders Treatment Market Research is meant to benefit stakeholders, vendors, and other participants in the industry. This report is of 197 pages long. The Bleeding Disorders Treatment market is expected to grow […]

Emulsifiers and heart health: a prospective cohort study reveals associations

In a recent study published in BMJ, researchers examined the relationships between the intake of food emulsifiers and cardiovascular disease (CVD) risk. Study: Food additive emulsifiers and risk of cardiovascular disease in the NutriNet-Santé cohort: prospective cohort study. Image Credit: New Africa/Shutterstock.com Background Emulsifiers are substances added to industrially processed food products to enhance texture […]

In early P. aeruginosa infections in CF, LasB enzyme may be target…

LasB, an enzyme that promotes Pseudomonas aeruginosa infections in the lungs of people with cystic fibrosis (CF), is significantly more active in the early stages of infection with the bacteria, known more simply as P. aeruginosa, a study revealed. These findings suggest that therapies targeting LasB may be most effective for the treatment of early-stage […]

Research Reveals Paxlovid Resistance in Persistent Infections

Columbia University Irving Medical Center Paxlovid is still a highly effective treatment for most people infected with SARS-CoV-2 and the drug prevents many hospitalizations and deaths from COVID. But for millions of immunocompromised people whose infections may persist for months, the antiviral drug can lose its effectiveness as the virus mutates. Although patients may initially […]

Dementia risk and AFib: Some blood thinners may help lower risk

Share on PinterestDirect oral anticoagulants are linked to a significantly lower incidence of dementia among some Asian populations with atrial fibrillation. Image credit: Ommaphat Chotirat/Getty Images. The use of direct oral anticoagulants, or ‘DOACs,’ is associated with a significantly lower incidence of dementia in a new study, compared to the use of traditional blood thinner […]

Is COVID back in Germany?

The COVID-19 pandemic is officially over and the World Health Organization (WHO) has declared it finished. Other news items have long superseded the coronavirus in the headlines. However, some Germans are worried because the number of recorded infections has been rising in recent weeks This is — still — no reason for concern, according to Professor Stefan Kluge, […]